BAX icon

Baxter International

30.62 USD
-0.74
2.36%
At close Jun 13, 4:00 PM EDT
After hours
31.03
+0.41
1.34%
1 day
-2.36%
5 days
0.66%
1 month
-1.70%
3 months
-11.37%
6 months
0.99%
Year to date
4.65%
1 year
-9.25%
5 years
-63.45%
10 years
-54.93%
 

About: Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Employees: 38,000

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

40% more call options, than puts

Call options by funds: $142M | Put options by funds: $102M

29% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 96

18% more capital invested

Capital invested by funds: $14.1B [Q4 2024] → $16.6B (+$2.58B) [Q1 2025]

17% more funds holding in top 10

Funds holding in top 10: 6 [Q4 2024] → 7 (+1) [Q1 2025]

2% more funds holding

Funds holding: 806 [Q4 2024] → 820 (+14) [Q1 2025]

0.31% more ownership

Funds ownership: 94.43% [Q4 2024] → 94.74% (+0.31%) [Q1 2025]

9% less repeat investments, than reductions

Existing positions increased: 270 | Existing positions reduced: 297

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$28
9%
downside
Avg. target
$31
0%
upside
High target
$33
8%
upside

2 analyst ratings

positive
0%
neutral
50%
negative
50%
Morgan Stanley
Patrick Wood
9%downside
$28
Underweight
Maintained
5 May 2025
Wells Fargo
Larry Biegelsen
8%upside
$33
Equal-Weight
Maintained
2 May 2025

Financial journalist opinion

Based on 5 articles about BAX published over the past 30 days

Neutral
GlobeNewsWire
3 days ago
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman Montana . The hotel needed a way to cool its event space while maintaining its historical charm.
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
Positive
24/7 Wall Street
6 days ago
3 Top Goldman Sachs Dividend Stock Picks Have Up to 73% Upside Potential
After a volatile stretch, yields in the Treasury bond market have stabilized. Concerns about the volatility in the bond and stock markets are leading investors to top-quality dividend stocks.
3 Top Goldman Sachs Dividend Stock Picks Have Up to 73% Upside Potential
Neutral
Business Wire
2 weeks ago
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 10:40 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Sunday, December 7, 2025. About Baxter At Baxter, we are everywhere healthcare h.
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
Positive
Zacks Investment Research
3 weeks ago
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
Positive
24/7 Wall Street
4 weeks ago
4 Goldman Sachs Conviction List Top Picks Are Blue Chip Dividend Stock Royalty
The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks.
4 Goldman Sachs Conviction List Top Picks Are Blue Chip Dividend Stock Royalty
Neutral
Seeking Alpha
1 month ago
The 'Goldilocks' Case For Baxter International
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health care stocks, including Baxter, underperformed expectations, with BAX peaking in April 2020 before declining. But the divestiture of the kidney care business will help the balance sheet, and management is optimistic toward 2025 performance.
The 'Goldilocks' Case For Baxter International
Neutral
Business Wire
1 month ago
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on July 1, 2025, to stockholders of record as of May 30, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of diagn.
Baxter Declares Quarterly Dividend
Neutral
Seeking Alpha
1 month ago
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Shafer - Chairman and Interim Chief Executive Officer Heather Knight - Chief Operating Officer Joel Grade - Executive Vice President and Chief Financial Officer Conference Call Participants Joanne Wuensch - Citi David Roman - Goldman Sachs Travis Steed - BofA Securities Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan Larry Biegelsen - Wells Pito Chickering - Deutsche Bank Danielle Antalffy - UBS Operator Good morning, ladies and gentlemen, and welcome to Baxter International's First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter and is copyrighted material.
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts.
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Positive
Benzinga
1 month ago
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps
On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps
Charts implemented using Lightweight Charts™